Escalon Medical Corp. (ESMC)
USD 0.2
(0.0%)
USD 0.2
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 279.4 Thousand USD | -11.31% |
| 2023 | 520.04 Thousand USD | -24.87% |
| 2022 | 692.22 Thousand USD | -11.85% |
| 2021 | 785.3 Thousand USD | -41.25% |
| 2020 | 1.33 Million USD | 8873.81% |
| 2019 | 14.89 Thousand USD | -17.41% |
| 2018 | 18.03 Thousand USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 4.5 Million USD | 54.51% |
| 2010 | 2.91 Million USD | -38.49% |
| 2009 | 4.74 Million USD | 1789.9% |
| 2008 | 250.87 Thousand USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 162.55 Thousand USD | -58.51% |
| 2005 | 391.79 Thousand USD | -83.65% |
| 2004 | 2.39 Million USD | -41.28% |
| 2003 | 4.08 Million USD | -21.4% |
| 2002 | 5.19 Million USD | 15.3% |
| 2001 | 4.5 Million USD | -8.12% |
| 2000 | 4.9 Million USD | 600.0% |
| 1999 | 700 Thousand USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 115.6 Thousand USD | -3.83% |
| 2024 Q3 | 278.77 Thousand USD | -2.5% |
| 2024 Q4 | 279.4 Thousand USD | -2.67% |
| 2024 Q2 | 285.93 Thousand USD | -2.82% |
| 2023 Q1 | 611.66 Thousand USD | -11.64% |
| 2023 Q4 | 520.04 Thousand USD | -14.61% |
| 2023 FY | 520.04 Thousand USD | -24.87% |
| 2023 Q3 | 609 Thousand USD | 15.21% |
| 2023 Q2 | 528.59 Thousand USD | -13.58% |
| 2022 Q4 | 692.22 Thousand USD | 13.27% |
| 2022 FY | 692.22 Thousand USD | -11.85% |
| 2022 Q1 | 732.89 Thousand USD | -6.67% |
| 2022 Q2 | 672.63 Thousand USD | -8.22% |
| 2022 Q3 | 611.13 Thousand USD | -9.14% |
| 2021 Q3 | 904.9 Thousand USD | -20.99% |
| 2021 Q2 | 1.14 Million USD | -3.92% |
| 2021 FY | 785.3 Thousand USD | -41.25% |
| 2021 Q1 | 1.19 Million USD | -10.83% |
| 2021 Q4 | 785.3 Thousand USD | -13.22% |
| 2020 Q2 | 802.36 Thousand USD | -6.53% |
| 2020 Q4 | 1.33 Million USD | 37.04% |
| 2020 FY | 1.33 Million USD | 8873.81% |
| 2020 Q1 | 858.45 Thousand USD | 5662.99% |
| 2020 Q3 | 975.46 Thousand USD | 21.57% |
| 2019 Q4 | 14.89 Thousand USD | -5.52% |
| 2019 FY | 14.89 Thousand USD | -17.41% |
| 2019 Q3 | 15.76 Thousand USD | -3.94% |
| 2019 Q2 | 16.41 Thousand USD | -4.54% |
| 2019 Q1 | 17.19 Thousand USD | -4.68% |
| 2018 FY | 18.03 Thousand USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q3 | 18.85 Thousand USD | 0.0% |
| 2018 Q4 | 18.03 Thousand USD | -4.33% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | -100.0% |
| 2012 Q1 | 4.16 Million USD | -7.65% |
| 2012 Q2 | 3.88 Million USD | -6.53% |
| 2012 Q3 | - USD | -100.0% |
| 2011 FY | 4.5 Million USD | 54.51% |
| 2011 Q4 | 4.5 Million USD | -0.0% |
| 2011 Q3 | 4.5 Million USD | 147.28% |
| 2011 Q2 | 1.82 Million USD | -43.63% |
| 2011 Q1 | 3.23 Million USD | 10.86% |
| 2010 FY | 2.91 Million USD | -38.49% |
| 2010 Q2 | 4.83 Million USD | -1.78% |
| 2010 Q1 | 4.92 Million USD | 3.87% |
| 2010 Q3 | 4.54 Million USD | -6.12% |
| 2010 Q4 | 2.91 Million USD | -35.78% |
| 2009 FY | 4.74 Million USD | 1789.9% |
| 2009 Q4 | 4.74 Million USD | -14.02% |
| 2009 Q3 | 5.51 Million USD | -6.31% |
| 2009 Q2 | 5.88 Million USD | 4592.24% |
| 2009 Q1 | 125.43 Thousand USD | -50.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | 250.87 Thousand USD | 0.0% |
| 2008 FY | 250.87 Thousand USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q2 | 66.89 Thousand USD | -29.76% |
| 2007 Q1 | 95.23 Thousand USD | -41.41% |
| 2007 FY | - USD | -100.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q3 | 14.11 Thousand USD | -78.9% |
| 2006 Q4 | 162.55 Thousand USD | -27.67% |
| 2006 FY | 162.55 Thousand USD | -58.51% |
| 2006 Q3 | 224.72 Thousand USD | -15.91% |
| 2006 Q2 | 267.26 Thousand USD | -18.91% |
| 2006 Q1 | 329.56 Thousand USD | -15.88% |
| 2005 Q1 | 594.21 Thousand USD | -75.2% |
| 2005 Q2 | 522.46 Thousand USD | -12.07% |
| 2005 FY | 391.79 Thousand USD | -83.65% |
| 2005 Q3 | 461.6 Thousand USD | -11.65% |
| 2005 Q4 | 391.79 Thousand USD | -15.12% |
| 2004 Q3 | 2.79 Million USD | -12.52% |
| 2004 Q4 | 2.39 Million USD | -14.31% |
| 2004 FY | 2.39 Million USD | -41.28% |
| 2004 Q2 | 3.19 Million USD | -12.8% |
| 2004 Q1 | 3.66 Million USD | -10.18% |
| 2003 Q2 | 3.76 Million USD | -15.98% |
| 2003 Q4 | 4.08 Million USD | -9.24% |
| 2003 FY | 4.08 Million USD | -21.4% |
| 2003 Q3 | 4.49 Million USD | 19.54% |
| 2003 Q1 | 4.47 Million USD | -13.78% |
| 2002 Q1 | 6.88 Million USD | 52.97% |
| 2002 Q4 | 5.19 Million USD | -10.21% |
| 2002 FY | 5.19 Million USD | 15.3% |
| 2002 Q3 | 5.78 Million USD | -8.08% |
| 2002 Q2 | 6.28 Million USD | -8.67% |
| 2001 Q3 | 4.91 Million USD | 8.08% |
| 2001 Q1 | 4.9 Million USD | 0.0% |
| 2001 Q2 | 4.55 Million USD | -7.14% |
| 2001 Q4 | 4.5 Million USD | -8.44% |
| 2001 FY | 4.5 Million USD | -8.12% |
| 2000 Q3 | 5.6 Million USD | 833.33% |
| 2000 Q1 | 700 Thousand USD | 0.0% |
| 2000 FY | 4.9 Million USD | 600.0% |
| 2000 Q4 | 4.9 Million USD | -12.5% |
| 2000 Q2 | 600 Thousand USD | -14.29% |
| 1999 Q3 | 800 Thousand USD | 0.0% |
| 1999 Q4 | 700 Thousand USD | -12.5% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | 700 Thousand USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| BioElectronics Corporation | 12.52 Million USD | 97.77% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -140.753% |
| Polarean Imaging plc | 74.84 Thousand USD | -273.305% |
| Avitar, Inc. | 3.89 Million USD | 92.829% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 161 Thousand USD | -73.543% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 37.839% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.91% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 98.519% |
| Össur hf. | 311.8 Million USD | 99.91% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 54.789% |
| Aurora Spine Corporation | 1.59 Million USD | 82.447% |
| BrainsWay Ltd. | 239 Thousand USD | -16.905% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 98.328% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.966% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -28.396% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -539.72% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 52.643% |
| Nanomix Corporation | 10.11 Million USD | 97.237% |
| Theraclion SA | 1.95 Million EUR | 85.677% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | 8.272% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -86.269% |
| Lombard Medical, Inc. | 28.02 Million USD | 99.003% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.687% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -14.845% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -96.309% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 43.211% |
| VMS Rehab Systems, Inc. | 106.45 USD | -262374.401% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 45.322% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 47.508% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 65.248% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 13.337% |
| Urologix, Inc. | 4.58 Million USD | 93.907% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 35.058% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 89.972% |
| SS Innovations International, Inc. | 1.91 Million USD | 85.375% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.987% |
| NIOX Group Plc | 500 Thousand USD | 44.119% |
| Fuse Medical, Inc. | 200 Thousand USD | -39.702% |
| Broncus Holding Corporation | 1.22 Million USD | 77.173% |
| Brain Scientific Inc. | 7378.00 USD | -3686.988% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -72.617% |
| Health Logic Interactive Inc. | - USD | -Infinity% |